{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:33:23Z","timestamp":1786120403912,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/mlr.0b013e31822d5de9","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T20:14:55Z","timestamp":1323807295000},"page":"1-9","source":"Crossref","is-referenced-by-count":29,"title":["Variations in the Use of an Innovative Technology by Payer"],"prefix":"10.1097","volume":"50","author":[{"given":"Andrew J.","family":"Epstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Ketcham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif S.","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Groeneveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210211","doi-asserted-by":"crossref","first-page":"932","DOI":"10.7326\/0003-4819-142-11-200506070-00012","article-title":"High and rising health care costs. Part 2: technological innovation.","volume":"142","author":"Bodenheimer","year":"2005","journal-title":"Ann Intern Med"},{"key":"R2-1-20210211","doi-asserted-by":"crossref","first-page":"w566","DOI":"10.1377\/hlthaff.W5.566","article-title":"A widening rift in access and quality: growing evidence of economic disparities.","volume":"24","author":"Hurley","year":"2005","journal-title":"Health Aff"},{"key":"R3-1-20210211","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1468-0009.2009.00564.x","article-title":"Health consequences of uninsurance among adults in the United States: recent evidence and implications.","volume":"8","author":"McWilliams","year":"2009","journal-title":"Milbank Q"},{"key":"R4-1-20210211","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1162\/0034653053970348","article-title":"Health insurance, treatment and outcomes: using auto accidents as health shocks.","volume":"87","author":"Doyle","year":"2005","journal-title":"Rev Econ Stat"},{"key":"R5-1-20210211","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/archinternmed.2011.141","article-title":"The impact of new cardiovascular device technology on health care costs.","volume":"171","author":"Groeneveld","year":"2011","journal-title":"Arch Intern Med"},{"key":"R6-1-20210211","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"key":"R7-1-20210211","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0140-6736(03)12275-1","article-title":"Drug-eluting stents in vascular intervention.","volume":"361","author":"Fattori","year":"2003","journal-title":"Lancet"},{"key":"R9-1-20210211","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2006.10.026","article-title":"Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.","volume":"48","author":"Pfisterer","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R10-1-20210211","doi-asserted-by":"crossref","first-page":"913","DOI":"10.7326\/0003-4819-144-12-200606200-00009","article-title":"Narrative review: drug-eluting stents for the management of restenosis: a critical appraisal of the evidence.","volume":"144","author":"Tung","year":"2006","journal-title":"Ann Intern Med"},{"key":"R11-1-20210211","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jcin.2010.06.014","article-title":"Acceptance, panic, and partial recovery: the pattern of usage of drug-eluting stents after introduction in the U.S.","volume":"3","author":"Krone","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"R12-1-20210211","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1056\/NEJMp068304","article-title":"Stent thrombosis reduxthe FDA perspective.","volume":"356","author":"Farb","year":"2007","journal-title":"N Engl J Med"},{"key":"R13-1-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.2011.551","article-title":"Coronary revascularization trends in the United States, 2001-2008.","volume":"305","author":"Epstein","year":"2011","journal-title":"JAMA"},{"key":"R14-1-20210211","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.","volume":"362","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"R15-1-20210211","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/archinte.167.12.1233","article-title":"Disparities in health care are driven by where minority patients seek care.","volume":"167","author":"Hasnain-Wynia","year":"2007","journal-title":"Arch Intern Med"},{"key":"R16-1-20210211","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.amjcard.2005.05.015","article-title":"Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes.","volume":"96","author":"Kandzari","year":"2005","journal-title":"Am J Cardiol"},{"key":"R17-1-20210211","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ahj.2006.03.005","article-title":"Patterns and outcomes of drug-eluting coronary stent use in clinical practice.","volume":"152","author":"Rao","year":"2006","journal-title":"Am Heart J"},{"key":"R18-1-20210211","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.amjcard.2007.05.039","article-title":"Differences in utilization of drug-eluting coronary stents by race and payer.","volume":"100","author":"Hannan","year":"2007","journal-title":"Am J Cardiol"},{"key":"R19-1-20210211","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.ahj.2008.07.012","article-title":"Disparity in drug-eluting stent utilization by insurance type.","volume":"156","author":"Kao","year":"2008","journal-title":"Am Heart J"},{"key":"R20-1-20210211","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jcin.2010.04.011","article-title":"Insurance type influences use of drug-eluting stents.","volume":"3","author":"Gaglia","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"R23-1-20210211","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data.","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"R24-1-20210211","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2307\/3109770","article-title":"Between- and within-cluster covariate effects in the analysis of clustered data.","volume":"54","author":"Neuhaus","year":"1998","journal-title":"Biometrics"},{"key":"R26-1-20210211","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1002\/sim.1524","article-title":"Separation of individual-level and cluster-level covariate effects in regression analysis of correlated data.","volume":"22","author":"Begg","year":"2003","journal-title":"Stat Med"},{"key":"R27-1-20210211","doi-asserted-by":"crossref","first-page":"739","DOI":"10.7326\/0003-4819-145-10-200611210-00006","article-title":"Insurance coverage and care of patients with non-ST-segment elevation acute coronary syndromes.","volume":"145","author":"Calvin","year":"2006","journal-title":"Ann Intern Med"},{"key":"R28-1-20210211","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/archinte.160.6.817","article-title":"Payer status and the utilization of hospital resources in acute myocardial infarction.","volume":"160","author":"Canto","year":"2000","journal-title":"Arch Intern Med"},{"key":"R29-1-20210211","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0167-6296(99)00009-0","article-title":"Physician fees and procedure intensity: the case of cesarean delivery.","volume":"18","author":"Gruber","year":"1999","journal-title":"J Health Econ"},{"key":"R30-1-20210211","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.297.2.joc60179","article-title":"Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.","volume":"297","author":"Eisenstein","year":"2007","journal-title":"JAMA"},{"key":"R31-1-20210211","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.106.618066","article-title":"Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry.","volume":"113","author":"Spertus","year":"2006","journal-title":"Circulation"},{"key":"R32-1-20210211","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJMsa0803410","article-title":"Cardiovascular outcomes after a change in prescription policy for clopidogrel.","volume":"359","author":"Jackevicius","year":"2008","journal-title":"N Engl J Med"},{"key":"R33-1-20210211","first-page":"290","article-title":"Pharmacy cost sharing, antiplatelet therapy utilization, and health outcomes for patients with acute coronary syndrome.","volume":"16","author":"Philipson","year":"2010","journal-title":"Am J Manag Care"},{"key":"R34-1-20210211","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1468-0009.2007.00489.x","article-title":"Hospitals strategies for orchestrating selection of physician preference items.","volume":"85","author":"Montgomery","year":"2005","journal-title":"Milbank Q"},{"key":"R35-1-20210211","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1541-9215.2005.03814.x","article-title":"Dollars and stents: the economics of drug-eluting stents.","volume":"3","author":"Woklhu","year":"2005","journal-title":"Am Heart Hosp J"},{"key":"R37-1-20210211","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1377\/hlthaff.27.3.803","article-title":"Hospital-physician gainsharing in cardiology.","volume":"27","author":"Ketcham","year":"2008","journal-title":"Health Aff"}],"container-title":["Medical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MLR.0b013e31822d5de9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:33:17Z","timestamp":1786048397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005650-201201000-00001"}},"subtitle":["The Case of Drug-Eluting Stents"],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mlr.0b013e31822d5de9","relation":{},"ISSN":["0025-7079"],"issn-type":[{"value":"0025-7079","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}